phosphatidylcholines has been researched along with Mycoses in 58 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 19 (32.76) | 18.2507 |
| 2000's | 37 (63.79) | 29.6817 |
| 2010's | 2 (3.45) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| de Sá, FA; Gelfuso, GM; Gratieri, T; Lima, EM; Taveira, SF | 1 |
| Ben-Ami, R; Kontoyiannis, DP; Lewis, RE | 1 |
| Barlow, DJ; Drake, AF; Foglia, F; Lawrence, MJ; Rogers, SE; Terry, AE | 1 |
| Kontoyiannis, DP; Mantadakis, E; Samonis, G | 1 |
| Ritter, J | 1 |
| Benjamin, DK; Dodds Ashley, E; Drew, RH; Duane Davis, R; Palmer, SM; Perfect, JR | 1 |
| Estany, C; Gómez, L; Martí, JM; Martino, R; Sierra, J; Subirà, M | 1 |
| Aguado, JM; González-Vidal, D; Lumbreras, C | 1 |
| Chu, A; Dominguez, EA; Gotz, V; Hooshmand-Rad, R; Morris, JA; Reed, MD; Weinberg, J | 1 |
| Perfect, JR | 2 |
| Seibel, NL; Walsh, TJ; Wiley, JM | 1 |
| Pappas, PG | 1 |
| Alexander, BD; Wingard, JR | 1 |
| Addison, RM; Alexander, BD; Alspaugh, JA; Chao, NJ; Dodds Ashley, ES; Perfect, JR | 1 |
| Saliba, F | 1 |
| Chandrasekar, P | 1 |
| Drew, R | 1 |
| Akard, LP; Dugan, MJ; Jansen, J; Leslie, JK; Mattison, R; Thompson, JM; Wack, MF | 1 |
| Adler-Moore, J; Avanesian, V; Edwards, JE; Fu, Y; Ibrahim, AS; Schwartz, J; Spellberg, B | 1 |
| Drees, M; Gupta, M; Hadley, S; Wickes, BL | 1 |
| Dockrell, DH; Metcalf, SC | 1 |
| Chamilos, G; Chemaly, R; Kontoyiannis, DP; Lewis, RE; Luna, M; Raad, II | 1 |
| Balagtas, J; Dvorak, CC; Gutierrez, K; Hong, DK; Sarwal, M; Sutherland, SM | 1 |
| Adler-Moore, JP; Proffitt, RT | 1 |
| Bolard, J; Brajtburg, J; Elberg, S; Kobayashi, GS | 1 |
| Lister, J | 1 |
| Barton, LL; Hutter, JJ; Patterson, TS; Shehab, ZM | 1 |
| Wingard, JR | 1 |
| Richardson, MD | 1 |
| Chu, P; Evans, C; Hazel, D; Kelsey, S; Mehta, J; Newland, A; Powles, R; Riley, U; Singhal, S; Treleaven, J | 1 |
| Merhav, H; Mieles, L | 1 |
| Adedoyin, A; Anaissie, E; Bernardo, JF; Bolsack, LE; Boyle, A; Branch, RA; DeValeriola, D; DeWit, S; Horwith, G; Kelly, E; Klasterksy, J; Llanos-Cuentas, A; Lopez-Berestein, G; Sculier, JP; Swenson, CE | 1 |
| Evans, ME; Gubbins, PO; Rapp, RP | 1 |
| Arney, KL; Judson, MA; Tiernan, R | 1 |
| Boyle, JA; Luke, RG | 1 |
| Anaissie, EJ; Bow, E; DiNubile, MJ; Hiemenz, JW; Horwith, G; Lee, L; Lister, J; Perfect, JR; Reboli, A; Seibel, NL; Silber, JL; Walsh, TJ | 1 |
| Bekersky, I; Boswell, GW; Buell, D | 1 |
| Chopra, R; Clark, AD; Franklin, IM; McKendrick, S; Tansey, PJ | 1 |
| Boyle, JA; Swenson, CE | 1 |
| Arndt, C; Chanock, SJ; Dinubile, MJ; Harris, RE; Hiemenz, J; Reboli, A; Seibel, NL; Walsh, TJ | 1 |
| Lee, L; Linden, P; Walsh, TJ | 1 |
| Martino, R; Sierra, J; Subirá, M; Sureda, A | 1 |
| Schiller, GJ; Winston, DJ | 1 |
| Leverger, G | 1 |
| Chan, KM; Linden, P; Williams, P | 1 |
| Ellis, RW; Fisher, NC; Hastings, JG; Jones, SG; Miller, SJ; Mutimer, DJ; Singhal, S | 1 |
| Adedoyin, A; Bolcsak, LE; Branch, RA; Hellmann, A; Horwith, G; Janoff, AS; Radowska, D; Swenson, CE | 1 |
| Böhnke, M; Frueh, BE; Goldblum, D; Zimmerli, S | 1 |
| Farmaki, E; Graybill, JR; Roilides, E; Tollemar, J; Torres-Rodríguez, JM; Walsh, TJ | 1 |
| Andrès, E; Auvrignon, A; Eyer, D; Guillemain, R; Herbrecht, R; Letscher-Bru, V; Leverger, G; Pailler, C; Schaison, G; Suc, A | 1 |
| Cortes, J; Estey, E; Fleming, RV; Husni, R; Kantarjian, HM; Lim, J; Pierce, S; Raad, I; Rolston, K | 1 |
| Frothingham, R | 1 |
| Davis, RD; Drew, RH; Kanj, SS; McConnell, RR; Palmer, SM; Perfect, JR; Tapson, VF; Whitehouse, JD | 1 |
| Collazos, J; Ibarra, S; Martínez, E; Mayo, J | 1 |
| Campos, F; Candolfi, E; Herbrecht, R; Letscher-Bru, V; Randriamahazaka, R; Waller, J | 1 |
| Arikan, S | 1 |
12 review(s) available for phosphatidylcholines and Mycoses
| Article | Year |
|---|---|
Immunocompromised hosts: immunopharmacology of modern antifungals.
Topics: Amphotericin B; Antifungal Agents; Antigens, Fungal; Azoles; beta-Glucans; Cytokines; Drug Combinations; Echinocandins; Humans; Immunity; Immunocompromised Host; Leukocytes; Mycoses; Phosphatidylcholines; Phosphatidylglycerols | 2008 |
Systemic mycoses in the immunocompromised host: an update in antifungal therapy.
Topics: Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Aspergillosis; Candidiasis; Deoxycholic Acid; Drug Combinations; Echinocandins; Fungal Proteins; Humans; Immunocompromised Host; Mycoses; Peptides; Peptides, Cyclic; Phosphatidylcholines; Phosphatidylglycerols; Triazoles | 2003 |
[Amphotericin B and its lipid formulations].
Topics: Amphotericin B; Antifungal Agents; Aspergillus; Candida; Drug Combinations; Humans; Liposomes; Mycoses; Phosphatidylcholines; Phosphatidylglycerols | 2002 |
Use of newer antifungal therapies in clinical practice: what do the data tell us?
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Candidiasis; Caspofungin; Deoxycholic Acid; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Combinations; Drug Resistance, Fungal; Echinocandins; Humans; Lipopeptides; Liposomes; Mycoses; Peptides, Cyclic; Phosphatidylcholines; Phosphatidylglycerols; Pyrimidines; Randomized Controlled Trials as Topic; Time Factors; Treatment Outcome; Triazoles; Voriconazole; Zygomycosis | 2004 |
Potential role of aerosolized amphotericin B formulations in the prevention and adjunctive treatment of invasive fungal infections.
Topics: Aerosols; Amphotericin B; Antifungal Agents; Chemistry, Pharmaceutical; Deoxycholic Acid; Drug Combinations; Humans; Incidence; Mycoses; Phosphatidylcholines; Phosphatidylglycerols; Treatment Outcome | 2006 |
Improved outcomes associated with advances in therapy for invasive fungal infections in immunocompromised hosts.
Topics: Amphotericin B; Antifungal Agents; Azoles; Drug Combinations; Humans; Immunocompromised Host; Mycoses; Peptides, Cyclic; Phosphatidylcholines; Phosphatidylglycerols; Treatment Outcome | 2007 |
Amphotericin B lipid preparations: what are the differences?
Topics: Amphotericin B; Animals; Antifungal Agents; Drug Combinations; Drug Therapy, Combination; Humans; Mycoses; Phosphatidylcholines; Phosphatidylglycerols | 2008 |
Lipid complexes of amphotericin B: the competitive picture.
Topics: Amphotericin B; Animals; Antifungal Agents; Cholesterol Esters; Drug Combinations; Humans; Mycoses; Phosphatidylcholines; Phosphatidylglycerols | 1997 |
Amphotericin B lipid complex.
Topics: Amphotericin B; Animals; Antifungal Agents; Deoxycholic Acid; Drug Combinations; Humans; Mycoses; Phosphatidylcholines; Phosphatidylglycerols | 1997 |
AmBisome (liposomal amphotericin B): a comparative review.
Topics: Amphotericin B; Antifungal Agents; Clinical Trials as Topic; Drug Combinations; Humans; Liposomes; Mycoses; Phosphatidylcholines; Phosphatidylglycerols | 1998 |
Antifungal compounds: controversies, queries and conclusions.
Topics: Amphotericin B; Animals; Antifungal Agents; Chemoprevention; Drug Combinations; Humans; Mice; Mycoses; Phosphatidylcholines; Phosphatidylglycerols | 2000 |
Pulmonary reactions during treatment with amphotericin B: review of published cases and guidelines for management.
Topics: Aged; Amphotericin B; Antifungal Agents; Drug Combinations; Female; Humans; Lung Diseases; Male; Mycoses; Phosphatidylcholines; Phosphatidylglycerols | 2001 |
12 trial(s) available for phosphatidylcholines and Mycoses
| Article | Year |
|---|---|
Comparative safety of amphotericin B lipid complex and amphotericin B deoxycholate as aerosolized antifungal prophylaxis in lung-transplant recipients.
Topics: Adolescent; Adult; Aerosols; Aged; Amphotericin B; Deoxycholic Acid; Double-Blind Method; Drug Combinations; Female; Heart-Lung Transplantation; Humans; Lung Diseases; Lung Transplantation; Male; Middle Aged; Mycoses; Phosphatidylcholines; Phosphatidylglycerols; Postoperative Complications; Racial Groups; Retrospective Studies | 2004 |
Low-dose amphotericin B lipid complex vs. conventional amphotericin B for empirical antifungal therapy of neutropenic fever in patients with hematologic malignancies--a randomized, controlled trial.
Topics: Adult; Amphotericin B; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Chemical and Drug Induced Liver Injury; Combined Modality Therapy; Drug Combinations; Female; Fever of Unknown Origin; Hematologic Neoplasms; Humans; Hypokalemia; Immunocompromised Host; Incidence; Kidney Diseases; Male; Middle Aged; Mycoses; Neutropenia; Peripheral Blood Stem Cell Transplantation; Phosphatidylcholines; Phosphatidylglycerols; Treatment Outcome | 2004 |
Assessment of nephrotoxicity in patients receiving amphotericin B lipid complex: a pharmacosurveillance study in Spain.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Child; Child, Preschool; Drug Combinations; Female; Humans; Incidence; Infant; Kidney Diseases; Leishmaniasis, Visceral; Male; Middle Aged; Mycoses; Phosphatidylcholines; Phosphatidylglycerols; Treatment Outcome | 2004 |
Non-comparative evaluation of the safety of aerosolized amphotericin B lipid complex in patients undergoing allogeneic hematopoietic stem cell transplantation.
Topics: Adolescent; Adult; Aerosols; Amphotericin B; Antifungal Agents; Drug Combinations; Drug Therapy, Combination; Female; Fluconazole; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Mycoses; Phosphatidylcholines; Phosphatidylglycerols; Safety; Transplantation, Homologous; Treatment Outcome | 2006 |
Delayed ABLC prophylaxis after allogeneic stem-cell transplantation.
Topics: Administration, Oral; Adolescent; Adult; Aged; Amphotericin B; Anti-Inflammatory Agents; Antifungal Agents; Child; Drug Administration Schedule; Drug Combinations; Female; Humans; Injections, Intravenous; Male; Middle Aged; Mycoses; Phosphatidylcholines; Phosphatidylglycerols; Pilot Projects; Postoperative Complications; Prednisone; Stem Cell Transplantation; Steroids; Time Factors; Treatment Outcome | 2006 |
Efficacy of amphotericin B lipid complex injection (ABLC) in bone marrow transplant recipients with life-threatening systemic mycoses.
Topics: Adolescent; Adult; Amphotericin B; Antifungal Agents; Bone Marrow Transplantation; Child; Child, Preschool; Creatinine; Drug Combinations; Female; Humans; Male; Middle Aged; Mycoses; Neutropenia; Phosphatidylcholines; Phosphatidylglycerols | 1997 |
Pharmacokinetic profile of ABELCET (amphotericin B lipid complex injection): combined experience from phase I and phase II studies.
Topics: Amphotericin B; Antifungal Agents; Antineoplastic Agents; Area Under Curve; Chromatography, High Pressure Liquid; Drug Combinations; Drug Interactions; Half-Life; HIV Infections; Humans; Kidney Diseases; Leishmaniasis, Mucocutaneous; Mycoses; Neutropenia; Phosphatidylcholines; Phosphatidylglycerols; Reference Values | 1997 |
Renal effects of amphotericin B lipid complex.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Aspergillosis; Candidiasis; Creatinine; Drug Combinations; Female; Humans; Kidney; Male; Meningitis, Cryptococcal; Middle Aged; Mycoses; Phosphatidylcholines; Phosphatidylglycerols | 1998 |
Amphotericin B lipid complex for invasive fungal infections: analysis of safety and efficacy in 556 cases.
Topics: Adult; Amphotericin B; Antifungal Agents; Aspergillosis; Candidiasis; Creatinine; Cryptococcosis; Drug Combinations; Female; Humans; Male; Mycoses; Phosphatidylcholines; Phosphatidylglycerols | 1998 |
Amphotericin B lipid complex in pediatric patients with invasive fungal infections.
Topics: Adolescent; Amphotericin B; Antifungal Agents; Aspergillosis; Candidiasis; Child; Child, Preschool; Creatinine; Drug Combinations; Female; Humans; Infant; Infant, Newborn; Male; Mycoses; Phosphatidylcholines; Phosphatidylglycerols; Zygomycosis | 1999 |
A pharmacokinetic study of amphotericin B lipid complex injection (Abelcet) in patients with definite or probable systemic fungal infections.
Topics: Adult; Amphotericin B; Antifungal Agents; Area Under Curve; Drug Combinations; Female; Half-Life; Humans; Infusions, Intravenous; Male; Middle Aged; Mycoses; Phosphatidylcholines; Phosphatidylglycerols | 2000 |
Comparison of amphotericin B lipid complex (ABLC) vs. ambisome in the treatment of suspected or documented fungal infections in patients with leukemia.
Topics: Acute Disease; Amphotericin B; Antifungal Agents; Antineoplastic Agents; Drug Combinations; Humans; Leukemia; Mycoses; Phosphatidylcholines; Phosphatidylglycerols | 2001 |
34 other study(ies) available for phosphatidylcholines and Mycoses
| Article | Year |
|---|---|
Liposomal voriconazole (VOR) formulation for improved ocular delivery.
Topics: Animals; Antifungal Agents; Cattle; Cholesterol; Fatty Acids, Monounsaturated; Keratitis; Liposomes; Microscopy, Electron, Transmission; Mycoses; Phosphatidylcholines; Quaternary Ammonium Compounds; Swine; Voriconazole | 2015 |
Small-angle neutron scattering studies of the effects of amphotericin B on phospholipid and phospholipid-sterol membrane structure.
Topics: Amphotericin B; Antifungal Agents; Cell Membrane; Cholesterol; Ergosterol; Humans; Kinetics; Lipid Bilayers; Models, Molecular; Molecular Structure; Mycoses; Neutron Diffraction; Phosphatidylcholines; Phospholipids; Scattering, Small Angle; Sterols; Temperature | 2011 |
Retrospective study of the renal effects of amphotericin B lipid complex when used at higher-than-recommended dosages and longer durations compared with lower dosages and shorter durations in patients with systemic fungal infections.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aminoglycosides; Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Calcineurin Inhibitors; Child; Child, Preschool; Creatinine; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Combinations; Female; Glomerular Filtration Rate; Humans; Infant; Male; Middle Aged; Mycoses; Phosphatidylcholines; Phosphatidylglycerols; Prospective Studies; Registries; Retrospective Studies; Vancomycin | 2004 |
Efficacy and safety of amphotericin B lipid complex in 548 children and adolescents with invasive fungal infections.
Topics: Adolescent; Adult; Amphotericin B; Antifungal Agents; Bone Marrow Transplantation; Child; Child, Preschool; Drug Combinations; Drug Interactions; Female; Humans; Infant; Infant, Newborn; Kidney Diseases; Male; Mycoses; Organ Transplantation; Phosphatidylcholines; Phosphatidylglycerols; Registries; Retrospective Studies | 2005 |
Amphotericin B lipid complex in the treatment of invasive fungal infections: results of the Collaborative Exchange of Antifungal Research (CLEAR), an industry-supported patient registry.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Child; Child, Preschool; Drug Combinations; Female; Humans; Infant; Male; Middle Aged; Mycoses; Phosphatidylcholines; Phosphatidylglycerols; Registries | 2005 |
Treatment of non-Aspergillus moulds in immunocompromised patients, with amphotericin B lipid complex.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Child; Child, Preschool; Drug Combinations; Female; Fusarium; Humans; Immunocompromised Host; Infant; Kidney; Male; Middle Aged; Mycoses; Opportunistic Infections; Phosphatidylcholines; Phosphatidylglycerols; Registries; Retrospective Studies; Treatment Outcome; Zygomycosis | 2005 |
Study of renal safety in amphotericin B lipid complex-treated patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Child; Child, Preschool; Drug Combinations; Female; Humans; Infant; Kidney Diseases; Male; Middle Aged; Mycoses; Phosphatidylcholines; Phosphatidylglycerols; Registries; Risk | 2005 |
Antifungals and renal safety--getting the balance right.
Topics: Amphotericin B; Antifungal Agents; Drug Combinations; Humans; Kidney; Liposomes; Mycoses; Phosphatidylcholines; Phosphatidylglycerols | 2006 |
The experience is CLEAR.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Clinical Trials as Topic; Cryptococcosis; Databases, Factual; Drug Combinations; Humans; In Vitro Techniques; Multicenter Studies as Topic; Mycoses; Phosphatidylcholines; Phosphatidylglycerols; Prospective Studies; Treatment Outcome; Zygomycosis | 2006 |
Comparison of antifungal treatments for murine fusariosis.
Topics: Amphotericin B; Animals; Antifungal Agents; Brain; Caspofungin; Drug Combinations; Echinocandins; Fusarium; Kidney; Lipopeptides; Male; Mice; Mice, Inbred BALB C; Mycoses; Neutropenia; Peptides, Cyclic; Phosphatidylcholines; Phosphatidylglycerols | 2006 |
Lecythophora mutabilis prosthetic valve endocarditis in a diabetic patient.
Topics: Amphotericin B; Antifungal Agents; Aortic Valve; Ascomycota; Diabetes Complications; Drug Combinations; Endocarditis; Heart Valve Prosthesis; Humans; Male; Middle Aged; Molecular Sequence Data; Mycoses; Phosphatidylcholines; Phosphatidylglycerols; Prosthesis-Related Infections; Pyrimidines; Sequence Analysis, DNA; Treatment Outcome; Triazoles; Voriconazole | 2007 |
Effects of liposomal amphotericin B versus an amphotericin B lipid complex on liver histopathology in patients with hematologic malignancies and invasive fungal infections: a retrospective, nonrandomized autopsy study.
Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Autopsy; Chemical and Drug Induced Liver Injury; Drug Carriers; Drug Combinations; Female; Hematologic Neoplasms; Humans; Liposomes; Liver; Male; Middle Aged; Mycoses; Phosphatidylcholines; Phosphatidylglycerols; Retrospective Studies | 2007 |
Liposomal amphotericin B associated with severe hyperphosphatemia.
Topics: Adolescent; Amphotericin B; Child; Drug Combinations; Female; Humans; Hyperphosphatemia; Male; Mycoses; Phosphatidylcholines; Phosphatidylglycerols; Renal Insufficiency | 2008 |
Amphotericin B incorporated into egg lecithin-bile salt mixed micelles: molecular and cellular aspects relevant to therapeutic efficacy in experimental mycoses.
Topics: Amphotericin B; Animals; Bile Acids and Salts; Cells, Cultured; Circular Dichroism; Drug Carriers; Drug Stability; Erythrocytes; Fibroblasts; Humans; Lipoproteins; Mice; Micelles; Mycoses; Phosphatidylcholines; Potassium; Spectrophotometry; Therapeutic Equivalency | 1994 |
Amphotericin B Lipid Complex (Abelcet) in the treatment of invasive mycoses: the North American experience.
Topics: Amphotericin B; Animals; Antifungal Agents; Dogs; Drug Combinations; Mice; Mycoses; North America; Phosphatidylcholines; Phosphatidylglycerols; Rats | 1996 |
Amphotericin B lipid complex treatment of a leukemic child with disseminated Fusarium solani infection.
Topics: Amphotericin B; Antifungal Agents; Child, Preschool; Dermatomycoses; Drug Combinations; Drug Resistance, Microbial; Female; Fusarium; Humans; Immunocompromised Host; Mycoses; Neutropenia; Paranasal Sinus Diseases; Phosphatidylcholines; Phosphatidylglycerols; Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1996 |
Criteria for use of amphotericin B lipid complex injections in adults and children.
Topics: Adult; Amphotericin B; Antifungal Agents; Child; Drug Combinations; Humans; Injections, Intravenous; Kidney Function Tests; Microbial Sensitivity Tests; Mycoses; Phosphatidylcholines; Phosphatidylglycerols; Treatment Outcome | 1996 |
Amphotericin B lipid complex (ABLC) for the treatment of confirmed or presumed fungal infections in immunocompromised patients with hematologic malignancies.
Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Bone Marrow Transplantation; Drug Combinations; Female; Hematologic Neoplasms; Humans; Immunocompromised Host; Male; Middle Aged; Mycoses; Phosphatidylcholines; Phosphatidylglycerols; Transplantation, Autologous; Transplantation, Homologous | 1997 |
Amphotericin B lipid complex in the treatment of invasive fungal infections in liver transplant patients.
Topics: Adult; Amphotericin B; Antifungal Agents; Drug Combinations; Drug Monitoring; Female; Humans; Liver Transplantation; Male; Middle Aged; Mycoses; Phosphatidylcholines; Phosphatidylglycerols; Transplantation, Homologous | 1997 |
Primary pulmonary involvement of Fusarium solani in a lung transplant recipient.
Topics: Amphotericin B; Antifungal Agents; Drug Combinations; Fusarium; Humans; Immunosuppressive Agents; Lung Diseases, Fungal; Lung Transplantation; Male; Middle Aged; Mycoses; Phosphatidylcholines; Phosphatidylglycerols; Soil Microbiology | 1997 |
A comparative analysis of lipid-complexed and liposomal amphotericin B preparations in haematological oncology.
Topics: Adult; Amphotericin B; Antifungal Agents; Creatinine; Drug Combinations; Female; Hematologic Neoplasms; Humans; Immune Tolerance; Leukocyte Count; Male; Mycoses; Neutrophils; Opportunistic Infections; Phosphatidylcholines; Phosphatidylglycerols; Retrospective Studies; Treatment Outcome; Water-Electrolyte Imbalance | 1998 |
ABELCET treatment.
Topics: Amphotericin B; Antifungal Agents; Drug Combinations; Humans; Liposomes; Mycoses; Phosphatidylcholines; Phosphatidylglycerols | 1999 |
Retrospective analysis of the dosage of amphotericin B lipid complex for the treatment of invasive fungal infections.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Child; Child, Preschool; Drug Combinations; Female; Humans; Infant; Kidney; Male; Middle Aged; Mycoses; Phosphatidylcholines; Phosphatidylglycerols; Regression Analysis; Retrospective Studies | 1999 |
Amphotericin B lipid complex at 3 mg/kg/day for treatment of invasive fungal infections in adults with haematological malignancies.
Topics: Adult; Amphotericin B; Antifungal Agents; Drug Combinations; Female; Humans; Leukemia; Male; Middle Aged; Mycoses; Phosphatidylcholines; Phosphatidylglycerols | 1999 |
Controlled trials of amphotericin B lipid complex and other lipid-associated formulations.
Topics: Amphotericin B; Antifungal Agents; Double-Blind Method; Drug Combinations; Fluconazole; Humans; Liposomes; Mycoses; Phosphatidylcholines; Phosphatidylglycerols; Randomized Controlled Trials as Topic | 2000 |
[Role of the lipid formulation of amphotericin B in pediatric oncohematology].
Topics: Amphotericin B; Child; Drug Combinations; Humans; Immunosuppression Therapy; Leukemia; Mycoses; Myeloproliferative Disorders; Phosphatidylcholines; Phosphatidylglycerols | 2000 |
Efficacy and safety of amphotericin B lipid complex injection (ABLC) in solid-organ transplant recipients with invasive fungal infections.
Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Child; Drug Combinations; Female; Humans; Kidney; Male; Middle Aged; Mycoses; Organ Transplantation; Phosphatidylcholines; Phosphatidylglycerols; Postoperative Complications; Retrospective Studies; Survival Rate | 2000 |
Targeted prophylaxis with amphotericin B lipid complex in liver transplantation.
Topics: Adult; Amphotericin B; Antifungal Agents; Aspergillus fumigatus; Candida; Candida albicans; Drug Combinations; Drug Resistance, Microbial; Female; Fluconazole; Humans; Liver Transplantation; Male; Medical Audit; Microbial Sensitivity Tests; Mycoses; Phosphatidylcholines; Phosphatidylglycerols; Postoperative Care; Postoperative Complications; Prospective Studies | 2000 |
Treatment of postkeratitis fusarium endophthalmitis with amphotericin B lipid complex.
Topics: Adult; Amphotericin B; Anterior Chamber; Antifungal Agents; Drug Combinations; Endophthalmitis; Eye Infections, Fungal; Female; Fusarium; Humans; Keratitis; Mycoses; Ophthalmic Solutions; Phosphatidylcholines; Phosphatidylglycerols; Visual Acuity | 2000 |
Efficacy of amphotericin B lipid complex in the treatment of invasive fungal infections in immunosuppressed paediatric patients.
Topics: Adolescent; Amphotericin B; Antifungal Agents; Aspergillosis; Candidiasis; Child; Child, Preschool; Creatinine; Drug Combinations; Female; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Infant; Leukemia; Lung Transplantation; Male; Mycoses; Phosphatidylcholines; Phosphatidylglycerols; Retrospective Studies | 2001 |
Mortality rates in comparative trials of formulations of amphotericin B.
Topics: Amphotericin B; Antifungal Agents; Drug Combinations; Fever; Humans; Liposomes; Mycoses; Neutropenia; Phosphatidylcholines; Phosphatidylglycerols; Randomized Controlled Trials as Topic; Treatment Outcome | 2001 |
Safety of aerosolized amphotericin B lipid complex in lung transplant recipients.
Topics: Adult; Aerosols; Amphotericin B; Antifungal Agents; Candidiasis; Drug Combinations; Heart-Lung Transplantation; Humans; Incidence; Lung Diseases; Lung Transplantation; Middle Aged; Mycoses; Peritonitis; Phosphatidylcholines; Phosphatidylglycerols; Postoperative Period; Prospective Studies; Respiratory Mechanics; Safety; Survival Analysis | 2001 |
Successful outcome of treatment of a disseminated infection due to Fusarium dimerum in a leukemia patient.
Topics: Amphotericin B; Antifungal Agents; Drug Combinations; Female; Fusarium; Humans; Middle Aged; Mycoses; Phosphatidylcholines; Phosphatidylglycerols; Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2002 |
Lipid-based antifungal agents.
Topics: Amphotericin B; Antifungal Agents; Drug Combinations; Humans; Lipids; Mycoses; Nystatin; Phosphatidylcholines; Phosphatidylglycerols | 2002 |